These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 110860)

  • 1. Electrophoretic characterization of tyrosinase in the coated vesicles of malignant melanoma.
    Mojamdar M; Imokawa G; Mishima Y
    J Dermatol; 1979 Feb; 6(1):5-8. PubMed ID: 110860
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophoretic profile of tyrosinase treated with neuraminidase in various subcellular fractions from mouse melanoma.
    Tomita Y; Moro S; Seiji M
    J Dermatol; 1979 Apr; 6(2):125-7. PubMed ID: 112132
    [No Abstract]   [Full Text] [Related]  

  • 3. [Active tyrosinase site in melanin synthesizing cells; biochemical study of GERL (author's transl)].
    Imokawa G; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1978 Mar; 88(4):275-87. PubMed ID: 97423
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation and biochemical characterization of tyrosinase-rich GERL and coated vesicle in melanin synthesizing cells.
    Imokawa G; Mishima Y
    Br J Dermatol; 1981 Feb; 104(2):169-78. PubMed ID: 6783060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
    Imokawa G; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
    [No Abstract]   [Full Text] [Related]  

  • 6. Granule-bound tyrosinase: solubilization and its relation to the soluble form of tyrosinase.
    Iwata K; Takeuchi T
    J Invest Dermatol; 1977 Feb; 68(2):88-92. PubMed ID: 401850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False dopa reaction in studies of mammalian tyrosinase: some characteristics and precautions.
    White R; Hu F; Roman NA
    Stain Technol; 1983 Jan; 58(1):13-9. PubMed ID: 6410541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GERL-coated vesicle system in the melanin synthesizing cell: its three-dimensional ultrastructure and tyrosinase activity (author's transl)].
    Ogura H; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(13):883-901. PubMed ID: 413959
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathology and ultrastructural characteristics of a hypomelanotic variant of transplantable hamster melanoma with elevated tyrosinase activity.
    Bomirski A; Wrzołkowa T; Arendarczyk M; Bomirska M; Kuklinska E; Słominski A; Moellmann G
    J Invest Dermatol; 1987 Nov; 89(5):469-73. PubMed ID: 3117904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitiliginous achromia with malignant melanoma. Tyrosinase activity and ultrastructural study of achromic and normal skin.
    Perrot H; Ortonne JP; Schmitt D
    Arch Dermatol Res (1975); 1977 Jan; 257(3):247-53. PubMed ID: 402121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte.
    Yamamoto H; Takeuchi T
    J Histochem Cytochem; 1981 Aug; 29(8):953-8. PubMed ID: 6792273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possible processing of tyrosinase in the Golgi complexes of the melanocyte.
    Tomita Y; Hariu A; Kato C; Seiji M
    J Dermatol; 1985 Feb; 12(1):43-6. PubMed ID: 3926845
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular localization of tyrosinase in human malignant melanoma cell lines.
    Foa C; Aubert C
    J Invest Dermatol; 1977 Jun; 68(6):369-78. PubMed ID: 405430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of tyrosinase isoenzymes from hamster melanoma.
    Pomerantz SH; Li JP
    Yale J Biol Med; 1973 Dec; 46(5):541-52. PubMed ID: 4205121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
    Kageshita T; Ono T; Arao T; Tomita Y
    Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoelectron microscopic demonstration of human melanosome associated antigens (HMSA) on melanoma cells: comparison with tyrosinase distribution.
    Akutsu Y; Jimbow K
    J Invest Dermatol; 1988 Feb; 90(2):179-84. PubMed ID: 3123559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
    Jimbow K; Jimbow M; Chiba M
    J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified method for the isolation of melanosomes from B16 melanoma.
    Haberman HF; Menon IA
    J Invest Dermatol; 1973 Feb; 60(2):67-72. PubMed ID: 4348133
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation and characterization of a Golgi-rich fraction from the Harding-Passey mouse melanoma.
    Seiji M; Moro S; Tomita Y
    Tohoku J Exp Med; 1978 Sep; 126(1):63-70. PubMed ID: 100898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
    Miranda M; Botti D
    Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.